UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Laboratory Measurement of the Anticoagulant Activity of the Non–Vitamin K Oral Anticoagulants

Journal of the American College of Cardiology, 2014-09, Vol.64 (11), p.1128-1139

2014

Volltextzugriff (PDF)

Laboratory Assessment of the Anticoagulant Activity of Direct Oral Anticoagulants

Chest, 2017-01, Vol.151 (1), p.127-138

2017

Volltextzugriff (PDF)

Prothrombin complex concentrates versus fresh frozen plasma for warfarin reversal. A systematic review and meta-analysis

Thrombosis and haemostasis, 2016-09, Vol.116 (5), p.879-890

2016

Volltextzugriff (PDF)

How I treat target-specific oral anticoagulant–associated bleeding

Blood, 2014-02, Vol.123 (8), p.1152-1158

2014

Volltextzugriff (PDF)

Safety of outpatient management of cancer-associated pulmonary embolism: a retrospective study

Haematologica (Roma), 2024-05

2024

Volltextzugriff (PDF)

A scoping review protocol on diagnostic strategies to detect occult malignancies in individuals with ischemic stroke

PloS one, 2023-07, Vol.18 (7), p.e0289048-e0289048

2023

Volltextzugriff (PDF)

Barriers and facilitators for optimizing oral anticoagulant management: Perspectives of patients, caregivers, and providers

PloS one, 2021-09, Vol.16 (9), p.e0257798

2021

Volltextzugriff (PDF)

Management of bleeding risk in patients who receive anticoagulant therapy for venous thromboembolism: Communication from the ISTH SSC Subcommittee on Predictive and Diagnostic Variables in Thrombotic Disease

Journal of thrombosis and haemostasis, 2022-08, Vol.20 (8), p.1910-1919

2022

Volltextzugriff (PDF)

Perceptions of patients and healthcare providers on patient education to improve oral anticoagulant management

Journal of evaluation in clinical practice, 2022-12, Vol.28 (6), p.1027-1036

2022

Volltextzugriff (PDF)

All-cause mortality after major gastrointestinal bleeding among patients receiving direct oral anticoagulants: a protocol for a systematic review and meta-analysis

Systematic reviews, 2022-12, Vol.11 (1), p.269-7, Article 269

2022

Volltextzugriff (PDF)

Anticoagulant‐associated gastrointestinal bleeding: Framework for decisions about whether, when and how to resume anticoagulants

Journal of thrombosis and haemostasis, 2021-10, Vol.19 (10), p.2383-2393

2021

Volltextzugriff (PDF)

Incidence of stroke in the first year after diagnosis of cancer-A systematic review and meta-analysis

Frontiers in neurology, 2022-09, Vol.13, p.966190

2022

Volltextzugriff (PDF)

Ciraparantag: the next anticoagulant airbag?

Blood, 2021-01, Vol.137 (1), p.10-11

Siegal, Deborah M.

2021

Volltextzugriff (PDF)

Laboratory Assessment of the Anticoagulant Activity of Direct Oral Anticoagulants: A Systematic Review

Chest, 2017-01, Vol.151 (1), p.127-138

2017

Volltextzugriff (PDF)

Considerations for use of direct oral anticoagulants in arterial disease

Research and practice in thrombosis and haemostasis, 2021-05, Vol.5 (4), p.e12502-n/a, Article e12502

2021

Volltextzugriff (PDF)

What we have learned about direct oral anticoagulant reversal

Hematology, 2019-12, Vol.2019 (1), p.198-203

Siegal, Deborah M

2019

Volltextzugriff (PDF)

Prothrombin complex concentrates for DOAC‐associated bleeding, global coagulation assays, and assessments of clinical hemostasis: How to gauge the impact?

Research and practice in thrombosis and haemostasis, 2020-07, Vol.4 (5), p.677-679

2020

Volltextzugriff (PDF)

Managing target-specific oral anticoagulant associated bleeding including an update on pharmacological reversal agents

Journal of thrombosis and thrombolysis, 2015-04, Vol.39 (3), p.395-402

Siegal, Deborah M.

2015

Volltextzugriff (PDF)

Acute management of bleeding in patients on novel oral anticoagulants

European heart journal, 2013-02, Vol.34 (7), p.489-498

2013

Volltextzugriff (PDF)

Andexanet Alfa for the Reversal of Factor Xa Inhibitor Activity

The New England journal of medicine, 2015-12, Vol.373 (25), p.2413-2424

2015

Volltextzugriff (PDF)

2020 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants: A Report of the American College of Cardiology Solution Set Oversight Committee

Journal of the American College of Cardiology, 2020-08, Vol.76 (5), p.594

2020

Volltextzugriff (PDF)

Urgent procedures or surgeries in patients receiving oral anticoagulants: a systematic literature review

Journal of thrombosis and thrombolysis, 2023-02, Vol.55 (2), p.197-202

2023

Volltextzugriff (PDF)

Full Study Report of Andexanet Alfa for Bleeding Associated with Factor Xa Inhibitors

The New England journal of medicine, 2019-04, Vol.380 (14), p.1326-1335

2019

Volltextzugriff (PDF)

Reversal of target-specific oral anticoagulants

Drug discovery today, 2014-09, Vol.19 (9), p.1465-1470

2014

Volltextzugriff (PDF)

Country and health expenditure are major predictors of withholding anticoagulation in atrial fibrillation patients at high risk of stroke

Open heart, 2023-12, Vol.10 (2), p.e002506

2023

Volltextzugriff (PDF)

1 – 25 von 135

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(128)
Mit Volltextzugriff
(106)

Publikationsform

Sprache

Englisch
(135)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Laboratory Measurement of the Anticoagulant Activity of the Non–Vitamin K Oral Anticoagulants

Laboratory Assessment of the Anticoagulant Activity of Direct Oral Anticoagulants

Prothrombin complex concentrates versus fresh frozen plasma for warfarin reversal. A systematic review and meta-analysis

How I treat target-specific oral anticoagulant–associated bleeding

Safety of outpatient management of cancer-associated pulmonary embolism: a retrospective study

A scoping review protocol on diagnostic strategies to detect occult malignancies in individuals with ischemic stroke

Barriers and facilitators for optimizing oral anticoagulant management: Perspectives of patients, caregivers, and providers

Management of bleeding risk in patients who receive anticoagulant therapy for venous thromboembolism: Communication from the ISTH SSC Subcommittee on Predictive and Diagnostic Variables in Thrombotic Disease

Perceptions of patients and healthcare providers on patient education to improve oral anticoagulant management

All-cause mortality after major gastrointestinal bleeding among patients receiving direct oral anticoagulants: a protocol for a systematic review and meta-analysis

Anticoagulant‐associated gastrointestinal bleeding: Framework for decisions about whether, when and how to resume anticoagulants

Incidence of stroke in the first year after diagnosis of cancer-A systematic review and meta-analysis

Ciraparantag: the next anticoagulant airbag?

Laboratory Assessment of the Anticoagulant Activity of Direct Oral Anticoagulants: A Systematic Review

Considerations for use of direct oral anticoagulants in arterial disease

What we have learned about direct oral anticoagulant reversal

Prothrombin complex concentrates for DOAC‐associated bleeding, global coagulation assays, and assessments of clinical hemostasis: How to gauge the impact?

Managing target-specific oral anticoagulant associated bleeding including an update on pharmacological reversal agents

Acute management of bleeding in patients on novel oral anticoagulants

Andexanet Alfa for the Reversal of Factor Xa Inhibitor Activity

2020 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants: A Report of the American College of Cardiology Solution Set Oversight Committee

Urgent procedures or surgeries in patients receiving oral anticoagulants: a systematic literature review

Full Study Report of Andexanet Alfa for Bleeding Associated with Factor Xa Inhibitors

Reversal of target-specific oral anticoagulants

Country and health expenditure are major predictors of withholding anticoagulation in atrial fibrillation patients at high risk of stroke

Suchergebnisse filtern